{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:49:03Z","timestamp":1790336943577,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.hrtlng.2012.11.007","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T09:15:55Z","timestamp":1356599755000},"page":"208-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Bronchodilator responsiveness in patients with chronic heart failure"],"prefix":"10.1016","volume":"42","author":[{"given":"Armine G.","family":"Minasian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.J.","family":"van den Elshout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.N. Richard","family":"Dekhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra J.E.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank F.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.P.C.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne F.","family":"Heijdra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2012.11.007_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cardfail.2008.06.004","article-title":"Alveolar gas diffusion abnormalities in heart failure","volume":"14","author":"Guazzi","year":"2008","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1378\/chest.125.2.669","article-title":"The pulmonary manifestations of left heart failure","volume":"125","author":"Gehlbach","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0033-0620(05)80018-0","article-title":"Pulmonary factors limiting exercise capacity in patients with heart failure","volume":"37","author":"Mancini","year":"1995","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0002-9149(94)90230-5","article-title":"Abnormalities of pulmonary function in patients with congestive heart failure, and reversal with ipratropium bromide","volume":"73","author":"Kindman","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00005344-200207000-00017","article-title":"Chronically inhaled salmeterol improves pulmonary function in heart failure","volume":"40","author":"Ng","year":"2002","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib6","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1183\/09031936.93.06101492","article-title":"Bronchodilating effect of ipratropium bromide in heart failure","volume":"6","author":"Rolla","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/eurheartj\/14.6.744","article-title":"Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failure","volume":"14","author":"Uren","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib8","first-page":"297","article-title":"Pulmonary function profile in chronic congestive heart failure and the effect of ipratropium bromide","volume":"52","author":"Khan","year":"2000","journal-title":"Indian Heart J"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib9","first-page":"875","article-title":"Pulmonary function test abnormalities in the elderly with systolic heart failure","volume":"65","author":"Kurzawa","year":"2007","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cardfail.2003.08.007","article-title":"The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry","volume":"10","author":"Witte","year":"2004","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-5273(00)00233-3","article-title":"The effect of salbutamol on skeletal muscle in chronic heart failure","volume":"73","author":"Harrington","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib12","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1056\/NEJM199305133281914","article-title":"Bronchial hyperresponsiveness in heart failure","volume":"328","author":"Moore","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archinte.1983.00350030039007","article-title":"Serial pulmonary function in patients with acute heart failure","volume":"143","author":"Light","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2796.2008.01975.x","article-title":"Chronic obstructive pulmonary disease in patients admitted with heart failure","volume":"264","author":"Iversen","year":"2008","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib15","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHBLI\/WHO workshop report. http:\/\/www.goldcopd.org;\u00a02010."},{"key":"10.1016\/j.hrtlng.2012.11.007_bib16","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib17","unstructured":"Global Initiative for asthma. Global strategy for asthma management and prevention. NHBLI\/WHO workshop report. http:\/\/www.ginasthma.org;\u00a02010."},{"key":"10.1016\/j.hrtlng.2012.11.007_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cardfail.2006.09.003","article-title":"The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients","volume":"13","author":"O'Hanlon","year":"2007","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jemermed.2007.11.056","article-title":"Should acute treatment with inhaled beta agonists be withheld from patients with dyspnea who may have heart failure?","volume":"40","author":"Maak","year":"2011","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15412550701341012","article-title":"Impact of bronchodilator use on the prevalence of COPD in population-based samples","volume":"4","author":"Perez-Padilla","year":"2007","journal-title":"COPD"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib23","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaci.2011.06.048","article-title":"Asthma in the elderly: current understanding and future research needs\u2013a report of a National Institute on Aging (NIA) workshop","volume":"128","author":"Hanania","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib25","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2011.02.020","article-title":"Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists","volume":"57","author":"Hawkins","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-12-6","article-title":"Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial","volume":"12","author":"Hanania","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cardfail.2012.02.002","article-title":"Bronchodilators in heart failure patients with COPD: is it time for a clinical trial?","volume":"18","author":"Mentz","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib28","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","article-title":"Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis","volume":"125","author":"Salpeter","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib29","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.300.12.1439","article-title":"Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"300","author":"Singh","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib30","doi-asserted-by":"crossref","first-page":"d3215","DOI":"10.1136\/bmj.d3215","article-title":"Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials","volume":"342","author":"Singh","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib31","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2165\/11318580-000000000-00000","article-title":"Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence","volume":"69","author":"Salpeter","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.hrtlng.2012.11.007_bib32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMp1008502","article-title":"The safety of tiotropium \u2013 the FDA's conclusions","volume":"363","author":"Michele","year":"2010","journal-title":"N\u00a0Engl J Med"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956312004037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956312004037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:32:50Z","timestamp":1758954770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956312004037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0147956312004037"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2012.11.007","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchodilator responsiveness in patients with chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2012.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}